Immune checkpoint inhibitor–associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation
-
Published:2021-11
Issue:
Volume:158
Page:208-216
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Chanson Noémie, Ramos-Casals Manuel, Pundole Xerxes, Suijkerbuijk Karijn, José de Barros e Silva Milton, Lidar Merav, Benesova KarolinaORCID, Leipe Jan, Acar-Denizli Nihan, Pradère Pauline, Michot Jean-MarieORCID, Voisin Anne- Laure, Suárez-Almazor Maria E., Radstake Timothy R.D., Fernandes Moça Trevisani Virginia, Schulze-Koops HendrikORCID, Melin Audrey, Robert Caroline, Mariette Xavier, Baughman Robert P., Lambotte Olivier, Ramos-Casals Manuel, Mariette Xavier, Lambotte Olivier, Kostine Marie, Khamashta Munther A., Calabrese Leonard, Suárez-Almazor Maria, Baldini Chiara, Bingham Clifton O., Gottenberg Jacques-Eric, Radstake Timothy R.D., Schaeverbeke Thierry, Schulze-Koops Hendrik, Brito-Zerón Pilar, Flores-Chávez Alejandra, Acar-Denizli Nihan
Funder
Novartis Gilead Sciences Bayer Genentech Actelion Pharmaceuticals
Subject
Cancer Research,Oncology
Reference27 articles.
1. Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers;Darvin;Exp Mol Med,2018 2. Immune-related adverse events of checkpoint inhibitors;Ramos-Casals;Nat Rev Dis Prim,2020 3. Sicca/Sjogren’s syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the international ImmunoCancer registry (ICIR). Clin exp rheumatol;Ramos-Casals;Supplement,2019 4. Sarcoidosis 5. Clinical phenotypes in sarcoidosis;Pereira;Curr Opin Pulm Med,2014
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|